CONTACT US

SIGN UP FOR OUR NEWSLETTER

  • LinkedIn - White Circle

SINGAPORE

LaunchPad @ one-north

71 Ayer Rajah Crescent

#03-20/21/23/24

Singapore 139951

CHINA

Biotech Innovation Works

No.29 Life Park Road

Room 202-010, Block D

Changping District, Beijing, China, 102206

UNITED STATES

1 Broadway, Cambridge MA 02142 USA

© 2019 by Esco Ventures Pte. Ltd.

WORK WITH US

Esco Ventures is redefining the therapeutics of tomorrow by supporting life science technologies addressing unmet medical needs. We are looking for passionate individuals who want to transform the life sciences industry.

 

Scientist/Senior Scientist (Hematology/Immunology) - CLOSED

Carmine Therapeutics, Singapore

Carmine Therapeutics is an Esco Ventures X company pioneering a powerful new class of drugs based on engineered red blood cells extracellular vesicles (RBCEVs), founded by Esco Ventures and Professors Harvey Lodish, Minh Le and Jiahai Shi. Carmine focuses on developing a therapeutic platform that would address some of the technological unmet needs related to the delivery of next generation therapies such as nucleic acid-based therapeutics. Carmine has assembled a stellar scientific advisory board and is well-capitalized to develop first-in-class therapies against genetic diseases. Carmine will be based in Singapore but also with operations in Cambridge, Massachusetts.

Carmine is looking for a Scientist/Senior Scientist to join us in this exciting venture. An ideal candidate is one who is independent, technically competent, and able to work efficiently across multiple projects. Individuals with PhD in hematology or immunology are preferred. This role may involve a relocation to Cambridge, Massachusetts and therefore candidates should ideally be Singaporeans or US citizens.

Esco Ventures Fellowship – Call for Applicants is now OPEN

Esco Ventures X, Singapore

Esco Ventures X launched the Morphosis Program in 2018, designed for the brightest scientific and budding entrepreneurial minds to embark on biotech venture creation in a VC environment. This full-time program is in 2 phases: in Phase 1 (6 months), Fellows will participate in generating novel venture hypotheses and working closely alongside academic experts and experienced investment professionals in a highly creative and collaborative environment. At the end of Phase 1, the venture hypotheses will be evaluated and selected projects will be incubated by Esco Ventures X over a period of a year, with the selected Fellow(s) embarking on Phase 2 of the program to lead the R&D towards achieving POC.

Call for Applicants for Morphosis II will close on 31 July 2019

Scientist (RNA & Molecular Biology) - CLOSED

Carmine Therapeutics, Singapore

Carmine Therapeutics is an Esco Ventures X company pioneering a powerful new class of drugs based on engineered red blood cells extracellular vesicles (RBCEVs), founded by Esco Ventures and Professors Harvey Lodish, Minh Le and Jiahai Shi. Carmine focuses on developing a therapeutic platform that would address some of the technological unmet needs related to the delivery of next generation therapies such as nucleotide-based drugs. Carmine has assembled a stellar scientific advisory board and is well-capitalized to develop first-in-class therapies against rare diseases and cancer. Carmine will be based in Singapore but also with operations in Cambridge, Massachusetts.

Carmine is looking for a Scientist to join us in this exciting venture. The candidate must be independent, technically competent and able to efficiently work across multiple projects. The ideal candidate is one who is energetic, innovative and highly motivated, with experience working with RNA and familiar with a wide variety of molecular biology techniques.

Scientist (Cell Biology) - CLOSED

Carmine Therapeutics, Singapore

Carmine Therapeutics is an Esco Ventures X company pioneering a powerful new class of drugs based on engineered red blood cells extracellular vesicles (RBCEVs), founded by Esco Ventures and Professors Harvey Lodish, Minh Le and Jiahai Shi. Carmine focuses on developing a therapeutic platform that would address some of the technological unmet needs related to the delivery of next generation therapies such as nucleotide-based drugs. Carmine has assembled a stellar scientific advisory board and is well-capitalized to develop first-in-class therapies against rare diseases and cancer. Carmine will be based in Singapore but also with operations in Cambridge, Massachusetts.

Carmine is looking for a Scientist to join us in this exciting venture. The candidate must be independent, technically competent and able to efficiently work across multiple projects. The ideal candidate is one who is energetic, innovative and highly motivated, with experience in cell biology and working with animal disease models.

Scientist (Protein Biochemistry / Assay Development) - CLOSED

Maiden Therapeutics, Singapore

This job opening is available to A*STAR Research Fellows only (available under T-Up scheme)


Maiden Therapeutics is a venture-backed start-up company developing a platform technology for drug discovery from human breastmilk. Breastfeeding infants is the gold standard for nutrition and disease risk reduction. Maiden captures the human milk microbiome and extracts individual molecules against disease-specific targets (Rare diseases and challenging Pharma targets). The platform technology integrates next generation microbiology techniques, function-driven assays, and functional metagenomics.

 

The successful scientist will be required to understand the entire platform technology process and integrate with the research team. This research output from this role will contribute to important research milestones in the company’s development. The primary scientific responsibility will be to develop and validate functional assays (cell or molecular target based) for individual disease-specific targets, that can be integrated to the platform process.

Analyst/Associate - CLOSED

Esco Ventures, Singapore

Esco Ventures is the corporate venture and life science investment arm of Esco Group. We invest in life sciences tools & diagnostics, women’s health & fertility and biotech (with a focus on enabling platform technologies), operating across Singapore, China and the US.

 

We have an opening for an analyst or associate (depending on experience). This is a perfect entry-level opportunity for a recent PhD graduate or junior Post Doc aiming at a career in venture capital.

Senior Research Scientist - CLOSED

Esco Ventures X, Singapore

Esco Ventures X is incubating exciting new life science and biotech venture companies with first-in-class science addressing unmet medical needs. A position is available for a Senior Research Scientist to participate in the development of a new platform technology drug discovery company.

Machine Learning / Artificial Intelligence Scientist - CLOSED

Singapore

Esco Ventures is incubating exciting new life science and biotech venture companies with first in class science addressing unmet medical needs. A position is available for a Machine Learning / Artificial Intelligence Scientist to participate in various innovative projects of the company with regards to problem formulation, model development, and such. The Machine Learning / Artificial Intelligence Scientist will work closely with all members of the Esco Ventures team as well as our Singapore based CEO and stand chances of potential stock options.

Venture Partner

Europe

Esco Ventures is the corporate venture and life science investment arm of Esco Group, which invests globally in therapeutics, diagnostics, life science tools and medical devices. We are looking to expand our footprint in Europe and looking for a Europe-based Venture Partner to scout, evaluate and lead deals; and network with academic TTOs, VCs and corporate partners in Europe.

Life Sciences Tools Entrepreneur-in-Residence

Singapore

Esco Ventures is seeking a Life Sciences Tools/Diagnostics platforms Entrepreneur-in-Residence to evaluate investment opportunities, filter unmet needs, scout/invent technologies, and launch/co-found a new internally created venture to develop a novel life sciences (and preferably diagnostics platform) technology, leading the R&D team/program for the new venture.

Scientist/Senior Scientist (Protein Biochemistry)

Carmine Therapeutics, Singapore

Carmine Therapeutics is an Esco Ventures X company pioneering a powerful new class of drugs based on engineered red blood cells extracellular vesicles (RBCEVs), founded by Esco Ventures and Professors Harvey Lodish, Minh Le and Jiahai Shi. Carmine focuses on developing a therapeutic platform that would address some of the technological unmet needs related to the delivery of next generation therapies such as nucleic acid-based therapeutics. Carmine has assembled a stellar scientific advisory board and is well-capitalized to develop first-in-class therapies against genetic diseases. Carmine will be based in Singapore but also with operations in Cambridge, Massachusetts.

Carmine is looking for a Scientist/Senior Scientist to join us in this exciting venture. An ideal candidate is one who is independent, technically competent, and able to work efficiently across multiple projects. Individuals with PhD in protein biochemistry are preferred. This role may involve a relocation to Cambridge, Massachusetts and therefore candidates should ideally be Singaporeans or US citizens.